| San Diego Biotechnology Network

Biocept to Relocate Corporate Offices and CLIA-Certified Laboratory to New San Diego Location

June 5, 2020 sandiegobiotech Comments Off

SAN DIEGO, June 5, 2020 /PRNewswire/ — Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of molecular technologies designed to provide physicians with clinically actionable information to improve the outcomes of patients with cancer, anno… […]

Ionis Pharmaceuticals to present at upcoming virtual investor conferences

June 5, 2020 sandiegobiotech Comments Off

CARLSBAD, Calif., June 5, 2020 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (Nasdaq: IONS), the leader in antisense therapeutics, today announced that management will present a company overview at the following virtual investor conferences:

Wil… […]

Neurocrine Biosciences to Present at the Goldman Sachs 41st Annual Global Healthcare Conference Webcast

June 4, 2020 sandiegobiotech Comments Off

Live Webcast will be on June 11, 2020

SAN DIEGO, June 4, 2020 /PRNewswire/ — Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will present at the Goldman Sachs 41st Annual Global Healthcare Conference Webcast at 9:40 a.m. ET on Thursday, June 11, 2020. K… […]

Halozyme Announces Janssen Receives European Marketing Authorization For Subcutaneous DARZALEX® Utilizing Halozyme’s ENHANZE® Technology For The Treatment Of Patients With Multiple Myeloma

June 4, 2020 sandiegobiotech Comments Off

– Approval Follows Positive Opinion by European Committee for Medicinal Products for Human Use (CHMP) in April 2020 and Applies to All Current IV DARZALEX® Indications in Frontline and Relapsed/Refractory Settings — Innovative, Fixed-dose Subcutaneous… […]

How cells solve their identity crisis

June 4, 2020 sandiegobiotech Comments Off

LA JOLLA—Cancer is often the result of DNA mutations or problems with how cells divide, which can lead to cells “forgetting” what type of cell they are or how to function properly. Now, Professor Martin Hetzer and a team of scientists have provided cla… […]

New Visa Restrictions will Make the U.S. Economic Downturn Worse

June 4, 2020 sandiegobiotech Comments Off

[…]

Heron Therapeutics Announces Publication of Results from Study 209, a Phase 2b Study of HTX-011 in Patients Undergoing Total Knee Arthroplasty

June 4, 2020 sandiegobiotech Comments Off

SAN DIEGO, June 4, 2020 /PRNewswire/ — Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet … […]

Medical Marijuana, Inc. Investment Company Kannalife, Inc. Appoints Terrence O. Tormey to Board of Advisors

June 4, 2020 sandiegobiotech Comments Off

SAN DIEGO, June 4, 2020 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands a… […]

Global Coalition for Adaptive Research (GCAR) Selects DelMar Pharmaceuticals’ VAL-083 to Participate in the GBM AGILE Pivotal Study, an Adaptive Clinical Trial Platform in Glioblastoma Multiforme

June 4, 2020 sandiegobiotech Comments Off

GBM AGILE is the world’s first global adaptive clinical trial platform for glioblastoma with regulatory support as a registrational studyVAL-083 selected as the next investigational therapy to be evaluated across multiple international trial sitesReduc… […]

Qualigen Therapeutics Receives U.S. Patent Notice of Allowance for its STARS(TM) Technology

June 4, 2020 sandiegobiotech Comments Off

CARLSBAD, Calif., June 4, 2020 /PRNewswire/ — Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (Qualigen or the Company) announced today that the United States Patent and Trademark Office has issued a Notice of Allowance for a U.S. patent, which will be … […]